autologous myogenic mesenchymal stem cell therapy (OrCell)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameautologous myogenic mesenchymal stem cell therapy (OrCell)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Myogenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsMyocardial InfarctionMyocardial Ischemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOrCell Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOrCell Ltd

Active IndicationsN/A

Inactive IndicationsMyocardial InfarctionMyocardial Ischemia

Other Information

ATC CodeN/A